相关实验视频

Updated: May 4, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

根据内分泌治疗骨干在随机UNIRAD试验中的辅助性常利的差异效益

M Saint-Ghislain¹, S Chabaud², F Dalenc³

¹Institut Curie, Paris, France; Centre Oscar Lambret, Lille, France.

|April 16, 2025

概括

在UNIRAD试验的小组分析表明,everolimus可能有利于高风险早期乳腺癌的绝经前妇女,特别是那些服用他莫西芬的妇女. 需要进一步的研究来证实这些发现,以进行个性化内分泌疗法.

科学领域:

在瘤学瘤学.
临床试验临床试验
药理学药理学是指药理学的学科.

背景情况:

在UNIRAD试验中,研究了为高风险的早期光线乳腺癌的内分泌疗法添加everolimus.
整体试验没有证明添加everolimus的显著益处.
本报告侧重于预先规定的和特此后的子组分析.

研究的目的:

在UNIRAD试验中,探索everolimus在特定患者亚组中的疗效.
为了研究更年期状态,内分泌治疗剂和everolimus反应之间的潜在相互作用.
为未来的临床试验设计产生假设.

主要方法:

随机,双盲试验,1278名患者被分配给安慰剂或Everolimus加内分泌治疗.
根据内分泌治疗,先前治疗,孕激素受体和淋巴结状况进行分层.
后期分析包括更年期状态,年龄和治疗坚持.

主要成果:

在接受他莫西芬治疗的患者中,发现了更有利的预后特征的趋势.
在绝经前的妇女中,Everolimus在3年无病生存期中显示出数值上的好处 (90%与86%相比).
在接受他莫西芬治疗的绝经前患者中观察到有利于everolimus的更强趋势 (91%vs84%DFS).

结论:

后期分析表明更年期状态,他莫西芬和埃弗罗利斯之间存在潜在的相互作用.
在高风险,ER-阳性,HER2-阴性早期乳腺癌患者中,Everolimus可能会带来好处,这些患者是绝经前和服用他莫西芬的.
对高风险的绝经前患者来说,单独使用他莫西芬治疗可能是不够的,这表明需要加强治疗策略.

关键词:

辅助疗法是一种辅助疗法.这是Everolimus.乳腺癌的发光方式在更年期前,更年期前,更年期前,更年期前.

更多相关视频

Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines

Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines

Published on: September 13, 2017

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

相关概念视频

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Clinical Trials

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...

Clinical Trials: Overview

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...

Bioavailability Study Design: Single Versus Multiple Dose Studies

Bioavailability Study Design: Single Versus Multiple Dose Studies

Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...